Literature DB >> 3872886

Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.

R A Eisenberg, K Dyer, S Y Craven, C R Fuller, W J Yount.   

Abstract

Anti-Sm antibodies are highly specific markers for the diagnosis of systemic lupus erythematosus (SLE). This specificity suggests that the immunoregulation of these autoantibodies would reflect fundamental immune abnormalities in this disorder. As a clue to this immunoregulation, we have investigated the isotype distribution of anti-Sm antibodies by enzyme-linked immunosorbent assays. We have found that the anti-Sm response is markedly restricted to the IgG1 heavy chain isotype. On the other hand, the light chain distribution reflects that in normal serum, while isoelectric focusing analysis fails to show an oligoclonal pattern. The related specificity, anti-ribonucleoprotein, is also restricted to IgG1, while the SLE-specific antibody anti-double-stranded DNA is mostly IgG1 with a lesser contribution by IgG3. These results suggest that antinuclear antibodies that are strongly associated with SLE are produced by a T cell-dependent response, probably driven by antigen. The immunoregulation of the response to several autoantigens may be quite similar.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872886      PMCID: PMC425455          DOI: 10.1172/JCI111826

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  The gammaG subclass of antinuclear and antinucleic acid antibodies.

Authors:  P H Schur; M Monroe; N Rothfield
Journal:  Arthritis Rheum       Date:  1972 Mar-Apr

2.  The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness.

Authors:  H L Spiegelberg; W O Weigle
Journal:  J Immunol       Date:  1968-08       Impact factor: 5.422

3.  Immunoglobulin classes and IgG subclasses of human antinuclear antibodies. A correlation of complement fixation and the nephritis of systemic lupus erythematosus.

Authors:  E M Puritz; W J Yount; M Newell; P D Utsinger
Journal:  Clin Immunol Immunopathol       Date:  1973-11

4.  Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX.

Authors:  I M Pike; W J Yount; E M Puritz; H R Roberts
Journal:  Blood       Date:  1972-07       Impact factor: 22.113

5.  Immunoglobulin G subclass of human antinuclear antibodies.

Authors:  T Tojo; G J Friou; H L Spiegelberg
Journal:  Clin Exp Immunol       Date:  1970-01       Impact factor: 4.330

6.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

7.  Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemia.

Authors:  W J Yount; M Seligmann; R Hong; R Good; H G Kunkel
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

8.  Immunoglobulin G subclasses of antinuclear antibodies and renal deposits. Comparison of systemic lupus erythematosus, drug-induced lupus and rheumatoid arthritis.

Authors:  J N Kacaki; M L Callerame; S E Blomgren; J H Vaughan
Journal:  Arthritis Rheum       Date:  1971 Mar-Apr

9.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  35 in total

1.  Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.

Authors:  S Oak; J Radtke; C Törn; M Landin-Olsson; C S Hampe
Journal:  Scand J Immunol       Date:  2011-10       Impact factor: 3.487

Review 2.  The role of autoantigens in the induction and maintenance of autoimmunity.

Authors:  P H Plotz
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus.

Authors:  G Fellows; N Gittoes; D G Scott; J S Coppock; A Wainwright; M Goodall; B M Turner
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

4.  Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus.

Authors:  T H Winkler; T A Henschel; I Kalies; H W Baenkler; F Skvaril; J R Kalden
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

5.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

6.  An IgG subclass imbalance in connective tissue disease.

Authors:  R A Kay; K J Wood; R M Bernstein; P J Holt; R S Pumphrey
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

7.  Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives.

Authors:  H Dang; M Takei; D Isenberg; Y Shoenfeld; R Backimer; J Rauch; N Talal
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

8.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

9.  T cell reactivity against the SmD1(83-119) C terminal peptide in patients with systemic lupus erythematosus.

Authors:  G Riemekasten; C Weiss; S Schneider; A Thiel; A Bruns; F Schumann; S Bläss; G-R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2002-09       Impact factor: 19.103

10.  In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner.

Authors:  Heike Albert; Mattias Collin; Diana Dudziak; Jeffrey V Ravetch; Falk Nimmerjahn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.